MedPath

Effects of two treatment techniques over the length and width step people with Parkinson's disease

Not Applicable
Conditions
Idiopathic Parkinson's disease
Registration Number
RBR-6bgqk4
Lead Sponsor
niversidade Estadual Paulista
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

will be included Male and female; with a diagnosis of idiopathic Parkinson's disease; classified in stages I to III of Hoehn Yahr; with the realization of independent walking without the use of assistive devices; which do not stage pharmacological adaptation; and can perform assessments and interventions on phase of medications for Parkinson's Disease.

Exclusion Criteria

Will be excluded those who experience pain; fracture; or serious injury to soft tissue in the six months previous history to the study and history of cardiovascular or respiratory changes uncontrolled and cognitive changes.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary Outcome: Increase in pitch length and gait speed and decrease the variability of step length, step width, step width variability, verified by the gait kinematic analysis in Peak program Motus Motion Measurement System after six weeks of training in addition to the improvement in mobility tests as the Short Physical Performance Battery (SPPB), the Timed up and Go (TUG) and quality of life, assessed by the Parkinson's Disease Questionnary - 39 (PDQ-39); all data will be statistically analyzed and adopted p <0.05 for significant values.
Secondary Outcome Measures
NameTimeMethod
Increased stride length and velocity of motion and decrease the variability of step length, step width, step width variability, verified by the gait kinematic analysis in Peak program Motus Motion Measurement System every two weeks of training, as well the improvement in mobility tests such as the Short Physical Performance Battery (SPPB), the Timed up and Go (TUG) and quality of life, assessed by the Parkinson's Disease Questionnary - 39 (PDQ-39); all data will be statistically analyzed and adopted p <0.05 for significant values.
© Copyright 2025. All Rights Reserved by MedPath